Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Share-based Compensation (2017 - 2021)

Cogent Biosciences has reported Share-based Compensation over the past 5 years, most recently at $3.9 million for Q4 2021.

  • Quarterly results put Share-based Compensation at $3.9 million for Q4 2021, up 344.8% from a year ago — trailing twelve months through Dec 2021 was $11.7 million (up 94.22% YoY), and the annual figure for FY2025 was $46.1 million, up 15.95%.
  • Share-based Compensation for Q4 2021 was $3.9 million at Cogent Biosciences, up from $3.5 million in the prior quarter.
  • Over the last five years, Share-based Compensation for COGT hit a ceiling of $3.9 million in Q4 2021 and a floor of $282000.0 in Q2 2017.
  • Median Share-based Compensation over the past 5 years was $853500.0 (2018), compared with a mean of $1.3 million.
  • Biggest five-year swings in Share-based Compensation: fell 8.37% in 2019 and later soared 345.69% in 2020.
  • Cogent Biosciences' Share-based Compensation stood at $460000.0 in 2017, then surged by 96.09% to $902000.0 in 2018, then dropped by 6.65% to $842000.0 in 2019, then grew by 2.85% to $866000.0 in 2020, then surged by 344.8% to $3.9 million in 2021.
  • The last three reported values for Share-based Compensation were $3.9 million (Q4 2021), $3.5 million (Q3 2021), and $2.6 million (Q2 2021) per Business Quant data.